Literature DB >> 15825407

Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.

P J Hyams, M S Simberkoff, J J Rahal.   

Abstract

Clinical isolates of Providencia and Proteus with relative aminoglycoside resistance were tested for susceptibility to combinations of gentamicin or tobramycin with cephalothin or cefazolin. The minimal bactericidal concentration of aminoglycoside for one-third of the strains was reduced by fourfold or more in the presence of one-fourth of the minimal bactericidal concentration of either cephalosporin. This effect was achieved by clinically attainable concentrations of cephalothin or cefazolin.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15825407      PMCID: PMC429016          DOI: 10.1128/AAC.5.6.571

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Acute renal failure after high doses of gentamicin and cephalothin.

Authors:  D Kleinknecht; D Ganeval; D Droz
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

2.  Cephalothin, gentamicin, colistin hazards.

Authors:  P D Hansten
Journal:  JAMA       Date:  1973-03-05       Impact factor: 56.272

3.  Providencia stuartii sepsis: a new challenge in the treatment of thermal injury.

Authors:  P W Curreri; H M Bruck; R B Lindberg; A D Mason; B A Pruitt
Journal:  Ann Surg       Date:  1973-02       Impact factor: 12.969

4.  Nebulizer contamination in a burn unit.

Authors:  A H Morris
Journal:  Am Rev Respir Dis       Date:  1973-05

5.  Anuria and acute tubular necrosis associated with gentamicin and cephalothin.

Authors:  S N Bobrow; E Jaffe; R C Young
Journal:  JAMA       Date:  1972-12-18       Impact factor: 56.272

6.  Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety.

Authors:  M Brzezinska; R Benveniste; J Davies; P J Daniels; J Weinstein
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

7.  Antimicrobial activity of the carbenicillin-gentamicin combination against gram-negative bacilli.

Authors:  J Klastersky; G Swings; D Daneau
Journal:  Am J Med Sci       Date:  1970-12       Impact factor: 2.378

8.  Bacteriological and clinical activity of the ampicillin-gentamicin and cephalothin-gentamicin combinations.

Authors:  J Klastersky; R Cappel; G Swings; L Vandenborre
Journal:  Am J Med Sci       Date:  1971-11       Impact factor: 2.378

9.  Acute renal failure associated with combined gentamicin and cephalothin therapy.

Authors:  J P Fillastre; R Laumonier; G Humbert; D Dubois; J Metayer; A Delpech; J Leroy; M Robert
Journal:  Br Med J       Date:  1973-05-19

10.  In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa.

Authors:  T C Eickhoff
Journal:  Appl Microbiol       Date:  1969-09
View more
  2 in total

Review 1.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.

Authors:  J C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.